| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 05/02/1991 | WO1991005858A1 A microperoxidase preparation containing a hemopeptide as an active component |
| 05/02/1991 | WO1991005841A1 Degradation resistant detergent compositions |
| 05/02/1991 | WO1991005840A1 Liquid enzymatic detergent composition |
| 05/02/1991 | WO1991005804A1 Catalysis of diels-alder reactions, methods and catalysts therefor |
| 05/02/1991 | EP0425004A2 Genetic manipulations with recombinant DNA comprising sequences derived from RNA virus |
| 05/02/1991 | EP0424498A1 Process for preparation of activated protein c. |
| 05/02/1991 | EP0424459A1 Dna encoding human monoamine oxidase type a |
| 05/02/1991 | EP0424429A1 New expression vectors |
| 05/02/1991 | EP0195802B1 Thermostable g(b)-amylase - |
| 05/02/1991 | CA2072616A1 Stabilized immobilized enzyme |
| 05/02/1991 | CA2027935A1 Imidazo [4,5-b] quinolinyloxyalkanoic acid amides with enhanced water solubility |
| 05/01/1991 | WO1991006651A1 Gene conferring salt tolerance |
| 05/01/1991 | WO1991006637A1 Subtilisin mutants |
| 05/01/1991 | CN1051058A Cloning and expression of microbial phytase |
| 05/01/1991 | CA2070395A1 Gene conferring salt tolerance |
| 04/30/1991 | US5011952 Phospholipase A2 inhibitor |
| 04/30/1991 | US5011795 Human tPA production using vectors coding for DHFR protein |
| 04/30/1991 | US5011776 Shuttle vector, utilizing the E. coli asparagine synthetase gene, and capable of dominant transfection and amplification in animal cells |
| 04/30/1991 | US5011773 Human esterase D, its uses and a process of purification |
| 04/30/1991 | US5011772 High yield protein production system |
| 04/30/1991 | US5011686 Injectable reagent with affinity for fibrin |
| 04/30/1991 | CA1283614C D-amino acid oxidase and method for isolation thereof |
| 04/28/1991 | WO1991006572A1 Diagnosis of glomerulonephritis |
| 04/28/1991 | WO1991006320A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
| 04/28/1991 | WO1991006303A1 Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
| 04/28/1991 | CA2071898A1 Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
| 04/28/1991 | CA2071530A1 Diagnosis of glomerulonephritis |
| 04/28/1991 | CA2071502A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
| 04/26/1991 | WO1991006673A1 ISOLATING OF STRAINS OF SACCHAROMYCES CEREVISIAE HAVING ALTERED Nα-ACETYLTRANSFERASE ACTIVITY |
| 04/26/1991 | WO1991006636A1 Identification of methionine n-alpha-acetyltransferase |
| 04/26/1991 | CA2071486A1 Isolating of strains of saccharomyces cerevisiae having altered n.alpha.-acetyltransferase activity |
| 04/26/1991 | CA2067757A1 Identification of methionine n-alpha-acetyltransferase |
| 04/25/1991 | WO1991006635A1 Method for producing secretable glycosyltransferases and other golgi processing enzymes |
| 04/24/1991 | WO1991005556A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
| 04/24/1991 | EP0424117A1 Yeast promoter |
| 04/24/1991 | EP0424064A1 Chiral azabicyloheptanone and a process for their preparation |
| 04/24/1991 | EP0424033A2 External skin preparation |
| 04/24/1991 | EP0423953A1 Method for creative kinase isoform separation |
| 04/24/1991 | EP0423943A2 Use of collagenase inhibitors in the treatment of demyelinating diseases, in particular multiple sclerosis |
| 04/24/1991 | EP0423938A1 Ligand-containing medium for chromatographic separation, process for preparing the medium, and use of the medium for isolating synthetic or natural molecules from a fluid mixture |
| 04/24/1991 | EP0423890A2 Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant DNA technology |
| 04/24/1991 | EP0423818A1 Arylsulfatase |
| 04/24/1991 | EP0423641A2 Expression vector, transformed microorganism, fusion protein and method for the production of platelet factor 4 or TGFalpha |
| 04/24/1991 | EP0423470A1 Method of preventing color change of food |
| 04/24/1991 | EP0423302A1 Application of novel dna fragments as a coding sequence for a signal peptide for the secretion of mature proteins by recombinant yeast, expression cassettes, transformed yeasts and corresponding process for the preparation of proteins. |
| 04/24/1991 | EP0423128A1 Novel restriction endonuclease |
| 04/24/1991 | CN1050899A Novel entities for cancer therapy |
| 04/24/1991 | CN1050879A Novel alpha-glucosidase inhibitors |
| 04/24/1991 | CA2067491A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
| 04/23/1991 | US5010204 Glaucoma treatment |
| 04/23/1991 | US5010182 DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
| 04/23/1991 | US5010015 Plasmid capable of multiplying in bacillus, regulation and secretion signal sequences of the amylase gene and the dna sequence encoding for the protein or polypeptide |
| 04/23/1991 | US5010008 Treating alpha-amylase with granular starch to absorb the enzyme, heating with calcium ion buffer |
| 04/23/1991 | US5010002 Human t-PA production using vectors coding DHFR protein |
| 04/23/1991 | US5010000 Method for the preparation of a selected protein or a part thereof in Bacillus strain bacteria |
| 04/23/1991 | US5009889 Treatment of dysfunctional vascular endothelium using activated protein C |
| 04/23/1991 | CA1283376C .alpha.-AMYLASE MIXTURES FOR STARCH LIQUEFACTION |
| 04/23/1991 | CA1283373C Use of the gal 1 yeast promoter |
| 04/21/1991 | CA2027916A1 Method and formulation for creatine kinase isoform separation |
| 04/20/1991 | WO1991005792A1 A dna fragment encoding a rubber polymerase and its related products |
| 04/20/1991 | CA2042359A1 Dna fragment encoding a rubber polymerase and its related products |
| 04/20/1991 | CA2027964A1 External skin preparation |
| 04/19/1991 | WO1991005908A1 Method for bleaching with reduced organic chlorides |
| 04/19/1991 | WO1991005794A1 Stable mammalian cell lines that express aromatase |
| 04/19/1991 | WO1991005793A1 Production and use of human nm23 protein and antibodies therefor |
| 04/19/1991 | CA2044279A1 Method for bleaching with reduced organic chlorides |
| 04/19/1991 | CA2044249A1 Stable mammalian cell lines that express aromatase |
| 04/18/1991 | WO1991005053A1 Cloning and expression of microbial phytase |
| 04/18/1991 | WO1991005048A1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use |
| 04/18/1991 | WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 04/18/1991 | WO1991005039A1 Thermostable purified endoglucanases from thermophilic bacterium acidothermus cellulolyticus |
| 04/18/1991 | WO1991002805A3 Recombinant retroviruses delivering vector constructs to target cells |
| 04/18/1991 | DE3934454A1 Vector for inducible protein over-expression in Bacillus - has tetracycline repressor gene and its adapted promoter, xylose isomerase promoter and tetracycline operator sequence |
| 04/17/1991 | EP0422975A1 Alpha-glucosidase inhibitors |
| 04/17/1991 | EP0422951A1 Method for producing the Hpa I restriction endonuclease and methylase |
| 04/17/1991 | EP0422790A2 Recombinant DNA expression vectors and DNA compounds that encode acyltransferase activity of aspergillus |
| 04/17/1991 | EP0422307A1 Novel alpha-glucosidase inhibitors |
| 04/17/1991 | EP0422079A1 Tricyclic lipoxygenase inhibiting compounds, compositions, methods of use |
| 04/17/1991 | EP0422049A1 Vector for secretion of proteins directly into periplasm or culture medium |
| 04/17/1991 | EP0414828A4 Process for the preparation of urokinase derivatives |
| 04/17/1991 | CA2027637A1 N-acetylmuramidase m1 |
| 04/16/1991 | US5008195 Some novel producers of cyclodextrin glycosyltransferases |
| 04/16/1991 | US5008194 nifH promoters of Bradyrhizobium |
| 04/16/1991 | US5008193 Glucose, 2-keto-gluconic acid, 2,5-diketogulonic acid |
| 04/16/1991 | CA1283072C Process for the isolation and separation of lysozyme and avidin from eggwhite |
| 04/16/1991 | CA1283068C Plasmid for expression of penicillin g amidase |
| 04/16/1991 | CA1283067C Plasmid having vanillic acid decomposing ability and process of producing the same |
| 04/16/1991 | CA1283047C Stabilized plasminogen activator precursor and method of producing the same |
| 04/14/1991 | WO1991005857A1 A method for growing enzyme crystals |
| 04/14/1991 | WO1991005839A1 Dye transfer inhibition |
| 04/14/1991 | CA2066733A1 Method for growing enzyme crystals |
| 04/10/1991 | EP0421919A2 Polygalacturonase encoding fungal expression system |
| 04/10/1991 | EP0421918A1 Pharmaceutical compositions |
| 04/10/1991 | EP0421861A1 2-Hydroxy thiophene- and furan derivatives condensed with a nitrogen containing ring, process for their preparation and their therapeutical application |
| 04/10/1991 | EP0421843A1 Process for treating a papermaking pulp with an enzymatic preparation to make paper or cardboard |
| 04/10/1991 | EP0421376A1 Multifunctional RNA with self-processing activity, its production and use |
| 04/10/1991 | EP0421139A2 Process for the production of human thyroid peroxidase |
| 04/10/1991 | EP0421109A2 Screening methods for protease inhibitors |
| 04/10/1991 | EP0420911A1 Gene therapy using gene fusions for genetic or acquired disorders. |
| 04/10/1991 | EP0420894A1 Large scale method for purification of high purity heparinase. |